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Abstract
Pomegranate (Punica granatum) has been used since ages as a folk medicine. 
Studies have shown that pomegranate extracts have a role in various signaling 
pathways involved in inflammation, cellular transformation, hyperproliferation, 
angiogenesis, initiation of tumorigenesis, and eventually suppressing the final 
steps of tumorigenesis and metastasis. In this chapter, we have discussed some of 
the polyphenolic constituents present in pomegranate and their medical value, and 
we then discussed studies on chemopreventive/chemotherapeutic properties of 
pomegranate against various types of cancer, such as skin, prostate, colon, head and 
neck and lung cancers in cell culture systems, animal models and humans.
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1. Introduction
The Pomegranate fruit (Punica granatum L.) is a perineal fruit of the family 
punicaceae, the fruit comprises of white to deep purple seeds covered in a spongy 
membrane which is further covered by the pericarp. It is available across the 
globe as a well-established folklore medicine owing to its anti-oxidant and anti-
inflammatory properties. Various useful medicinally active components are 
present in the peel, seed, flower and even the leaves. The phenolic components 
comprise the major medicinally active part of the pomegranate extract along 
with minerals like magnesium, phosphorous, sodium and potassium [1–3]. 
There are four groups of phenolic compounds present in pomegranate namely 
the groups with anthocyanin pigments, hydrolysable tannins like punicalagin, 
ellagic acid and hydrolysable tannins. All of which contribute to the antioxidant 
activity. Moreover, it is rich in flavonoids and tannic acids which further adds 
to its the medicinal value. The antioxidant and anti-inflammatory potential of 
pomegranate juice and pomegranate extracts puts it apart from other fruits owing 
to the high concentrations of hydrolysable tannins and anthocyanins along with 
the polyphenols [4]. Among the various parts of the fruit, the peel and lamella 
which are the main on edible parts of the fruit has majority of the phenolic contents 
compared to the other edible parts. The peel accounts for more than half of the total 
antioxidative potential of the fruit and their anti-proliferative activity [5, 6]. The 
seed coat of the fruit also presents with numerous organic acids including citric acid 
Pomegranate
2
and ascorbic acid [7]. Among the major biomedical advantages of pomegranate is 
the anti-cancer activity since pomegranate and its various components has been 
prove to assist the treatment of cancer and show immunomodulatory activity [8]. 
This chapter will be discussing on the anti-cancer activity of pomegranate and its 
antioxidant activity.
Cancer is one of the most common disease conditions which is becoming the 
leading cause of death even when detected in its early stages. In the year of 2021, 
almost 2 million new cancer cases are expected to happen just in the united states. 
The cancer death is reducing with each decade comparing to the initial few decades 
since its peak. With each passing year, there is rapid improvement in the cancer 
treatment strategies [9]. Pomegranate components can be used for treatment of 
many ailments as such or as an adjuvant in the treatment. One of the common 
problems related to cancer therapy is the lack of specificity in differentiating the 
cancer cells from the normal cells which manifests problems in the oral cavities as 
mucositis or candidiasis. This shows the prospect of using pomegranate extracts 
as an adjuvant in normal cancer chemotherapy in order to improve the quality of 
life of the people undergoing treatment. Also, the rind extract rich in the tannin 
punicalagin when used in combination with zinc is shows healing activity in the oral 
cavity due to the anti-inflammatory activity [10, 11].
2. Pomegranate and prostate cancer
Prostate cancer is the most prevalent type of cancer in men with an incidence 
rate above 30 worldwide [12]. From the multicenter studies conducted in human 
prostate cancer using pomegranate extracts rich in polyphenols, the extracts were 
found to cause an inhibition in the proliferation of the cells in both in vivo and 
in vitro studies. Hence the study demonstrated a significant anticancer activity 
through the inhibition of invasion and proliferation of the cancer cells [13]. The 
initial stages of prostate cancer will be testosterone dependent and this can be 
treated with normal radiation or chemotherapy but not in the late stages which 
shows no dependence with testosterone. The Further studies on the extracts from 
different parts of pomegranate showed a synergic activity in the anti-proliferative 
activity of other components of pomegranate. The seed oil from pomegranate acts 
as a synergistic when used in conjunction with the juice rich in polyphenols in the 
prevention of proliferation even though it does not have any anti-proliferative effect 
alone [14].
The studies on LNCaP cell lines which are modified to over express androgen 
receptors so that a situation similar to that of androgen independent prostate cancer. 
By using the different pomegranate extracts rich in polyphenols, the study later on 
showed a decrease in expression of the gene for the androgen synthesizing enzymes. 
Since the down regulation of androgen receptors is evident from the study, 
pomegranate extracts can be of use in the treatment of prostate cancer with an 
up-regulation of androgen receptors [15]. In androgen independent prostate cancer, 
there is an observed activation of the nuclear factor NF-κB. The activation of this 
nuclear factor is a common event in many types of cancer including breast cancer 
and cervical cancer [16]. In the molecular studies conducted using pomegranate 
extracts on the activity of NF-κB. It was found that the pomegranate extracts were 
able inhibit the NF-κB activity which was shown in the androgen independent cells, 
DU145 with increasing doses. Congruent results were obtained from the electro 
mobility shift assay conducted on the same cells using pomegranate extracts. In the 
DU145 and CL-1 cells which are the androgen independent cell lines, the activity of 
NF-κB was found to be activated through the TNF-α. Pomegranate extracts showed 
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promising activity in the inhibition of NF-κB cells activated in this way as well. In 
the LAPC4 xenograft induced model of cancer, the extracts from pomegranate was 
found to delay the initiation of prostate cancer through prevention of proliferation 
of the cells [17].
Punicalagin is an important polyphenol constituent of pomegranate and as 
discussed before, the antioxidant activity of which is very evident in the cancer 
cells. The antiproliferative activity of punicalagin was examined in previous 
studies using the DPPH assay and the lipid peroxidation inhibition assays. Along 
with this, the study checked the cytotoxic activity and viability effects were also 
determined using punicalagin. It was found that punicalagin inhibited proliferation 
of cancer cells in prostate cancer and that the prostate cancer cells remained intact 
in the presence of punicalagin which was further supported by evidences from cell 
viability assays. The antioxidant activity of the polyphenol was further shown in 
the DPPH free radical scavenging assay which showed that it scavenged the free 
radicals in a dose dependent manner. The lipid peroxidation was also inhibited in 
the presence of punicalagin. PC-3 is another major cell line which is involved in 
prostate cancer and the polyphenol was found to reduce the PC-3 cells through 
apoptosis with higher concentrations [18, 19].
Further, it was found that pomegranate extracts affect the bio synthesis of 
androgens from the studies conducted using prostate cancer models. In the in 
vivo study conducted on the animal model using PTEN (Phosphatase and tensin 
homolog) knockout mouse which represents prostate cancer, there was observable 
reduction in the levels of steroids in the serum and in the case of in vitro studies 
using prostate cancer cell lines LNCaP and 22RV1, pomegranate extracts were 
found to cause a fall in the production of androgens. The in vitro and in vivo date 
obtained from various studies further shows the possible activity of pomegranate 
extracts in the treatment of Prostate cancer [20].
3. Pomegranate and breast cancer
Breast cancer is the most common type of cancer diagnosed in women and 
the leading cause of death due to cancer in women with over 2 million cases being 
diagnosed from recent studies [21]. The major causative factor for the cancer 
proliferation in breast cancer proliferation is estrogen and the enzymes which 
catalyzes the production of estrogen. The enzyme aromatase aids in the conversion 
of androgen into estrogen. So, the inhibition of this enzyme can further aid in 
the treatment of breast cancer. In vitro studies conducted on one of the major 
constituents of the pomegranate namely extract ellagic acid and urolithins A and 
B showed promising results on the inhibition of aromatase enzyme. The placental 
microsome aromatase assay conducted on ellagitannin derived compounds from 
pomegranate extracts namely, methylated urolithin B, methylated urolithin A 
and urolithin A further showed the aromatase inhibiting activity of pomegranate 
extracts. Which in turn inhibits the proliferation of cancer cells [22].
From the in vivo studies conducted on mammary organ culture in mice using the 
pomegranate seed oil rich in punicic acid and the fermented fruit extracts, it was 
found that the extracts of pomegranate caused a reduction in the number of lesions 
obtained and supports the activity of pomegranate extracts in the treatment of 
breast cancer [23].
The in vitro studies conducted on cancer stem cells derived from MMTV-
Wnt-1, pomegranate extract was found to inhibit the proliferation of cancer cell by 
arresting the cell cycle at an early phase and induced apoptosis of the cancer cells. 
Pomegranate extracts caused an elevation I the levels of the enzyme caspase 3 which 
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aids in the apoptosis. Among the various extracts, ellagic acid and ursolic acid 
along with luteolin were found to cause the inhibition of cell proliferation. Also, 
pomegranate extracts showed promising results in the molecular studies conducted 
on the MCF-7 cells of breast cancer through the inhibition of proliferation of the 
cancer cells. In the MCF-7 cells, the anti-cancer activity was found to be due to the 
cell cycle arrest, down regulation of genes which proliferate the cancer cells and also 
through the upregulation of the genes which aids in the regulation of proliferation 
and apoptosis. Hence, pomegranate extracts are relevant in the treatment of breast 
cancer therapy in the cases which are relatively resistant to the existing agents of 
treatment [24, 25].
4. Pomegranate and colon cancer
Colorectal cancer is currently one of the most common diagnosed cancer in men 
and women and it manifests with the uncontrolled proliferating of the epithelial 
cells and the suppression of their apoptosis [26]. One of the major constituents 
of pomegranate, the ellagitannin urolithin A plays a key role in the inhibition of 
proliferation of colon cancer cells through cell cycle arrest and the inhibition of 
mitogen activated protein kinase signaling (MAPK) [27].
The action of ellagitannins and urolithin on the CYP1 enzymes is important as 
these enzymes lead to the activation of inactive carcinogens into active carcinogenic 
chemicals in colon cancer. In the cell line study using HT-29 colon cancer cells, 
the evaluation of activity of CYP1 enzyme by employing EROD assay (ethoxy 
resorufin-O-deethylase assay) showed a reduction of CYP1 enzymes which were 
induced in the cell line. The extracts were found to show selective inhibition of 
proliferation of the cells omitting the non-cancer cells in a dose dependent fashion. 
Further, ellagitannin and urolithin was found to cause an increase in the apoptosis 
of the cell lines resulting in a reduction of the cell colony [28].
From the animal studies conducted on rats which were induced with colon cancer 
using N-methylnitrosourea which caused an increase in antigens which were specific 
to colon cancer along with and increase in plasma levels of Bcl2 and TGF-β, it was 
found that pomegranate peel extracts caused a fall in the cancer specific parameters 
which were induced in the mice. The in vivo study further suggests the efficacy of 
pomegranate in the treatment of colon cancer through the inhibition of proliferation 
and increased apoptosis which was evident from the fall in CEA and CCSA-4 
prostate cancer cell markers along with the down regulation of β-catenin genes 
which has a pivotal role in the advancement of colon cancer. The down regulation of 
the specific gene disrupts the signaling pathway involving Wnt/β-catenin [29, 30].
From the cell line studies using HCT116 and HT-29 colon cancer cell lines, 
pomegranate extracts comprising of punicalagin, ellagic acid and tannins showed 
a drastic antiproliferative activity which led to complete inhibition of proliferation 
depending on the dose. The extract was found to cause apoptosis in the selected cell 
lines. Further, the extracts were found to have effect on the colon cancer cells which 
were not metastatic. The cell line studies further cement the role of punicalagin, 
ellagic acid and pomegranate tannins in the cancer protective activity in colon 
cancer [31].
5. Pomegranate and head and neck cancer
Head and neck cancers are one of the prevalent type of cancer which usually 
includes squamous cell carcinomas found in the epithelial cells of the pharynx, 
5
Role of Pomegranate in the Management of Cancer
DOI: http://dx.doi.org/10.5772/intechopen.97188
larynx and the oral cavity [32]. Due to the underdeveloped methods of screening 
of the disease, the chances of predicting the cancer at an early stage is less. This 
condition further leads to the increase in number of people who are diagnosed at 
a late stage of disease progression. In the current scenario, the treatment strategy 
of the disease mainly involves chemoradiation and surgery. The therapeutic 
approach to head and neck cancer comes with the common side effects of mucositis 
and dermatitis. Pomegranate extracts were studied for its protective effect in 
ameliorating the side effects of the treatment. In the clinical setup of a cohort 
containing patients with head and neck cancer, it was found that the extracts 
reduced the extend of damage caused by radiation induced dermatitis as well as 
mucositis [33].
Radiation therapy is applied in the cancer therapy for a long time because of 
its ability to kill the tumor cells but this will also lead to the production of reactive 
oxygen species that will damage the normal adjacent cells. Pomegranate extract 
has been studied in the amelioration of cellular damage induced by these reactive 
oxidants. From a study conducted using the extracts from pomegranate fruit and 
seeds, it was found that the treatment with the extracts increased the levels of 
antioxidant and the enzymes which has antioxidant property. Further the extracts 
were found to cause a decline in the lipid peroxidation levels suggesting the 
protective effect of pomegranate extracts in the cancer treatment as an adjuvant to 
reduce the unwanted side effects [34].
Other than in chemoradiation, pomegranate fruit extracts rich in punicalagin 
has been found useful in acting as a protective agent for the skin fibroblast cells 
namely the SKU-1064 from possible apoptosis due to UV-A and UV-B exposure. 
The extracts were found to suppress the NF- κB activation and through the 
downregulation of caspase-3 which is proapoptotic. Further studies found an 
increase in DNA repair through the increase in G0/G1 phase [35]. All these 
findings further supports the fact that pomegranate extracts can be applied in 
the treatment of cancer as an adjuvant also as a protective for radiation induced 
cellular damage.
6. Pomegranate and lung cancer
Lung cancer is one of the leading causes of death related to cancer worldwide in 
both men and women. Cigarette smoking is attributed to e the major cause of the 
condition. Along with lung cancer, cigarette smoke causes an increase in oxidative 
stress and DNA damage. From the animal studies conducted on the formation 
of lung nodules associated with lung cancer and other cancer related factors like 
the attenuation of mitosis and the levels of hypoxia inducible factor-1α or HIF1 
α because of cigarette smoke, it was found that pomegranate juice supplements 
wee able to reduce the formation of lung nodules which is a common observation 
in the case of cigarette smoke exposure along with the reduction of mitosis and 
HIF-1 α [36].
Further, pomegranate fruit extract treatment in the cell line study using 
human carcinoma cell associated with lung cancer namely the A549 cells showed 
an inhibition of the markers of cell proliferation and angiogenesis such as MAPK, 
NIF-kappa B and PI3K/Akt. The treatment with the extracts further arrested the 
growth of tumor cells. Thus, pomegranate may be useful as a chemo preventive 
or as a chemotherapeutic agent against cancer affecting lungs [37]. Methotrexate 
is a widely used chemotherapeutic agent but it causes injuries in the lung cells 
due to oxidative stress. In the animal studies employed to study the effect of 
pomegranate extracts on the protective action against the lung injury caused 
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due to methotrexate, it was found that the use of pomegranate extracts as a 
prophylactic significantly reduced the total oxidant status and the oxidative stress 
index along with elevating the total antioxidant capacity. This in turn shows the 
application of pomegranate extracts as an adjuvant as well in the therapy of lung 
cancer [38, 39].
7. Pomegranate and skin cancer
Pomegranate extracts from seed, peel and the whole fruit have been proven to 
be beneficial in the treatment of many cancer treatments. Skin cancer is the most 
common cancer among the Caucasian population and it varies depending on the 
type of cells affected. UV radiation is the major cause of skin cancer since it initiates 
and promotes tumor [40]. The in vivo and in vitro studies has shown the efficacy 
of pomegranate as a protectant in the UVB radiation induced skin damage. The 
oral treatment of pomegranate juice and extract in the Fitzpatrick II-IV skin type 
showed the possibility of enhancement in the protective from UV damage since 
it is able to increase the threshold of the UV dose required to cause erythema of 
skin [41].
The oil extracted from seed of pomegranate fruit was studied on animals 
as a topical prophylactic in the mice which was induced with skin cancer using 
12-O-tetradecanoylphorbol 13-acetate and 7,12-dimethylbenzanthracene and it was 
found that the pre-treated animals had a significant less incidence of skin cancer 
which tells the protective effect of pomegranate in skin cancer [42]. From the 
studies conducted on the human skin fibroblasts SKU-1064 which were irradiated 
with UV, it was found that the pomegranate extracts rich in punicalagin was able to 
prevent the skin cell death showing the effect of pomegranate as a topical protective 
agent against skin cancer [35].
8. Conclusion
Pomegranate and the products derived from it has been proven to show various 
medicinal properties. Even though it has been in use in various traditional medical 
folklore since ages, the medicinal property of pomegranate is not explored much to 
be of use in the current medical scenario. Pomegranate is still being used as just a 
fruit and from the studies which are conducted so far on the fruit, it is to be noted 
that the extracts of the fruit rather than the whole fruit as such possesses many 
medicinal properties.
The role of pomegranate in the therapy of cancer as such and as an adjuvant in 
therapy is explored very less as there are very few studies has been conducted on 
humans, even though there are a handful of studies which are conducted on animal 
models or cell line studies which deems the fruit and its extracts effective in the 
therapy of cancer. The studies conducted so far shows the potency of pomegranate 
and its components in the treatment of cancer relating to prostate, breast, head 
and neck, colon, lungs and skin or as an adjuvant in the treatment to minimize the 
unwanted side effects. The various components of pomegranates because of its 
antioxidant and anti-inflammatory property can be applied to various treatment 
strategies in numerous types of cancer in one way or the other.
Hence it can be concluded that pomegranate extracts can be made to much use 
for humans in improving the treatment strategies in turn improving the quality of 
life, for which there has to be more human, animal and cell line studies so that the 
complete potency of pomegranate can be uncovered.
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